| dc.relation.references | 1. ABOYANS, V. et al. 2017 ESC Guidelines on the Diagnosis and Treatment of
Peripheral Arterial Diseases, in collaboration with the European Society for Vascular
Surgery (ESVS). 2017.
2. ABOYANS, V. et al. Editor’s choice – 2017 ESC Guidelines on the Diagnosis and
Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for
Vascular Surgery (ESVS). European Journal of Vascular and Endovascular Surgery,
v. 55, n. 3, p. 305–368, mar. 2018.
3. ALAHDAB, F. et al. A systematic review for the screening for peripheral arterial
disease in asymptomatic patients. Journal of Vascular Surgery, v. 61, n. 3 Suppl, p.
42S-53S, mar. 2015.
4. AL-QAISI, M. Ankle brachial pressure index (ABPI): An update for practitioners.
Vascular Health and Risk Management, p. 833, set. 2009.
5. AMERICAN DIABETES ASSOCIATION. Peripheral arterial disease in people with
diabetes. Diabetes Care, v. 26, n. 12, p. 3333–3341, 1 dez. 2003.
6. ANDRAS, A.; FERKET, B. Screening for peripheral arterial disease. Cochrane
Database of Systematic Reviews, v. 2014, n. 4, 7 abr. 2014.
7. BERRY, J. D. et al. Lifetime risks of cardiovascular disease. New England Journal
of Medicine, v. 366, n. 4, p. 321–329, 26 jan. 2012.
8. BRIDGWOOD, B. M. et al. Knowledge of peripheral artery disease: What do the
public, healthcare practitioners, and trainees know? Vascular Medicine, v. 25, n. 3, p.
263–273, jun. 2020.
9. BÜRKNER, P. C. brms: An R package for Bayesian multilevel models using Stan.
Journal of Statistical Software, v. 80, n. 1, p. 1–28, 2017
10. CAO, P. et al. Chapter II: Diagnostic methods. European Journal of Vascular and
Endovascular Surgery, v. 42, p. S13–S32, dez. 2011.
105
11. CERQUEIRA, L. O.; DUARTE JÚNIOR, E. G.; BARROS, A. L. S.; CERQUEIRA,
J. R.; ARAÚJO, W. J. B. Classificação WIfI: o novo sistema de classificação da Society
for Vascular Surgery para membros inferiores ameaçados, uma revisão de literatura.
*Jornal Vascular Brasileiro*, v. 19, p. e20190070, 2020. Disponível em:
https://doi.org/10.1590/1677-5449.190070. Acesso em: [coloque a data de acesso aqui].
12. CHEN, Q. et al. Critical appraisal of international guidelines for the screening and
treatment of asymptomatic peripheral artery disease: A systematic review. BMC
Cardiovascular Disorders, v. 19, n. 1, p. 17, dez. 2019.
13. CHUTER, V. et al. Effectiveness of bedside investigations to diagnose peripheral
artery disease among people with diabetes mellitus: A systematic review.
Diabetes/Metabolism Research and Reviews, v. 40, n. 3, p. e3683, mar. 2024.
14. CHUTER, V. H. et al. Estimating the diagnostic accuracy of the ankle–brachial
pressure index for detecting peripheral arterial disease in people with diabetes: A
systematic review and meta‐analysis. Diabetic Medicine, v. 38, n. 2, p. e14379, fev.
2021.
15. COLLETT, D. Modelling Binary Data. London: Chapman and Hall, 1991.
16. COOKE, J. P.; CHEN, Z. A compendium on peripheral arterial disease. Circulation
Research, v. 116, n. 9, p. 1505–1508, 24 abr. 2015.
17. CRIQUI, M. H. et al. Lower extremity peripheral artery disease: Contemporary
epidemiology, management gaps, and future directions: A scientific statement from the
American Heart Association. Circulation, v. 144, n. 9, 31 ago. 2021.
18. CRIQUI, M. H.; ABOYANS, V. Epidemiology of peripheral artery disease.
Circulation Research, v. 116, n. 9, p. 1509–1526, 24 abr. 2015.
19. DE BARROS E SILVA, P. G. M. et al. Primary results of the Brazilian registry of
atherothrombotic disease (NEAT). Scientific Reports, v. 14, n. 1, p. 4222, 20 fev. 2024.
20. EVERHART, J. E. et al. Medial arterial calcification and its association with mortality
and complications of diabetes. Diabetologia, v. 31, n. 1, p. 16–23, jan. 1988.
106
21. GERHARD-HERMAN, M. D. et al. 2016 AHA/ACC guideline on the management
of patients with lower extremity peripheral artery disease: Executive summary: A report
of the American College of Cardiology/American Heart Association Task Force on
Clinical Practice Guidelines. Circulation, v. 135, n. 12, 21 mar. 2017.
22. GORNIK, H. L. et al. 2024
ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the
management of lower extremity peripheral artery disease. Journal of the American
College of Cardiology, p. S0735109724003814, maio 2024.
23. GUIRGUIS-BLAKE, J. M. et al. Screening for peripheral artery disease using the
ankle-brachial index: Updated evidence report and systematic review for the US
Preventive Services Task Force. JAMA, v. 320, n. 2, p. 184, 10 jul. 2018.
24. HACKLER, E. L.; HAMBURG, N. M.; WHITE SOLARU, K. T. Racial and ethnic
disparities in peripheral artery disease. Circulation Research, v. 128, n. 12, p. 1913–
1926, 11 jun. 2021.
25. HO, C. Y.; SHANAHAN, C. M. Medial arterial calcification: An overlooked player
in peripheral arterial disease. Arteriosclerosis, Thrombosis, and Vascular Biology, v.
36, n. 8, p. 1475–1482, ago. 2016.
26. JOOSTEN, M. M. et al. Associations between conventional cardiovascular risk
factors and risk of peripheral artery disease in men. JAMA, v. 308, n. 16, p. 1660, 24 out.
2012.
27. JUDE, E. B. et al. Peripheral arterial disease in diabetic and nondiabetic patients.
Diabetes Care, v. 24, n. 8, p. 1433–1437, 1 ago. 2001.
28. KASHETSKY, N. et al. Diagnostic accuracy of ankle-brachial pressure index
compared with Doppler arterial waveforms for detecting peripheral arterial disease: A
systematic review. Advances in Skin & Wound Care, v. 35, n. 4, p. 195–201, abr. 2022.
29. KIEBACK, A. G.; GÄHWILER, R.; THALHAMMER, C. PAD screening: why?
whom? when? how? – A systematic review. Vasa, v. 50, n. 2, p. 85–91, 1 fev. 2021.
107
30. LANZER, P. et al. Medial vascular calcification revisited: Review and perspectives.
European Heart Journal, v. 35, n. 23, p. 1515–1525, 1 jun. 2014.
31. LANZER, P. et al. Medial Arterial Calcification. Journal of the American College
of Cardiology, v. 78, n. 11, p. 1145–1165, set. 2021.
32. LEW, E.; NICOLOSI, N.; BOTEK, G. Lower extremity amputation risk factors
associated with elevated ankle-brachial indices and radiographic arterial calcification.
The Journal of Foot and Ankle Surgery, v. 54, n. 3, p. 473–477, maio 2015.
33. LOW WANG, C. C. et al. Cardiovascular and limb outcomes in patients with diabetes
and peripheral artery disease. Journal of the American College of Cardiology, v. 72, n.
25, p. 3274–3284, dez. 2018.
34. MAKDISSE, M. et al. Versão em português, adaptação transcultural e validação do
Questionário de Claudicação de Edimburgo. Arquivos Brasileiros de Cardiologia, v.
88, n. 5, p. 501–506, maio 2007.
35. MARSO, S. P.; HIATT, W. R. Peripheral arterial disease in patients with diabetes.
Journal of the American College of Cardiology, v. 47, n. 5, p. 921–929, mar. 2006.
36. MATSUSHITA, K. et al. Lifetime risk of lower‐extremity peripheral artery disease
defined by ankle‐brachial index in the United States. Journal of the American Heart
Association, v. 8, n. 18, p. e012177, 17 set. 2019.
37. MAZZOLAI, L. et al. 2024 ESC guidelines for the management of peripheral arterial
and aortic diseases. European Heart Journal, p. ehae179, 30 ago. 2024.
38. MURABITO, J. M. et al. Intermittent claudication: A risk profile from the
Framingham Heart Study. Circulation, v. 96, n. 1, p. 44–49, jul. 1997.
39. NARULA, J. et al. Histopathologic characteristics of atherosclerotic coronary disease
and implications of the findings for the invasive and noninvasive detection of vulnerable
plaques. Journal of the American College of Cardiology, v. 61, n. 10, p. 1041–1051,
mar. 2013.
108
40. NORGREN, L. et al. Inter-society consensus for the management of peripheral
arterial disease (TASC II). Journal of Vascular Surgery, v. 45 Suppl S, p. S5-67, jan.
2007.
41. NORMAHANI, P. et al. A systematic review and meta-analysis of the diagnostic
accuracy of point-of-care tests used to establish the presence of peripheral arterial disease
in people with diabetes. Journal of Vascular Surgery, v. 73, n. 5, p. 1811–1820, maio
2021.
42. NORMAHANI, P. et al. Study protocol for a multicentre comparative diagnostic
accuracy study of tools to establish the presence and severity of peripheral arterial disease
in people with diabetes mellitus: The DM PAD study. BMJ Open, v. 12, n. 11, p.
e066950, 3 nov. 2022.
43. PANDE, R. L.; CREAGER, M. A. Socioeconomic inequality and peripheral artery
disease prevalence in US adults. Circulation: Cardiovascular Quality and Outcomes,
v. 7, n. 4, p. 532–539, jul. 2014.
44. PARASKEVAS, K. I.; PHILLIPS, M. J.; SHEARMAN, C. P. Screening for
peripheral arterial disease using the ankle-brachial index in diabetic and other high-risk
patients: Pros and cons. Angiology, v. 67, n. 7, p. 607–609, ago. 2016.
45. R CORE TEAM. R: A language and environment for statistical computing. Vienna:
R Foundation for Statistical Computing, 2012. ISBN 3-900051-07-0, 2014.
45. SALLE, L.; MAGNE, J.; KENNE MALAHA, A.; CHASTAINGT, L.; GALINAT,
S.; DRUTEL, A.; LACROIX, P.; TEISSIER-CLÉMENT, M. P.; ABOYANS, V.
Ultrasound-detected tibial artery calcification as a marker of cardiovascular and lowerlimb risk in asymptomatic patients with type-2 diabetes. Vascular Medicine, v. 28, n. 6,
p. 538–546, dez. 2023. DOI: 10.1177/1358863X231190433. Disponível em:
https://pubmed.ncbi.nlm.nih.gov/37610880. Acesso em: 7 dez. 2024.
109
46. SANTOS, V. P. D. et al. Arteriosclerose, aterosclerose, arteriolosclerose e esclerose
calcificante da média de Monckeberg: qual a diferença? Jornal Vascular Brasileiro, v.
20, p. e20200211, 2021.
47. SHARMA, A. et al. Prevalence of calcification in the pedal arteries in diabetes
complicated by foot disease. Diabetes Care, v. 33, n. 5, p. e66–e66, 1 maio 2010.
48. SINGHANIA, P. et al. Toe brachial index and not ankle brachial index is appropriate
in initial evaluation of peripheral arterial disease in type 2 diabetes. Diabetology &
Metabolic Syndrome, v. 16, n. 1, p. 52, 27 fev. 2024.
49. SONG, P. et al. Global, regional, and national prevalence and risk factors for
peripheral artery disease in 2015: an updated systematic review and analysis. The Lancet
Global Health, v. 7, n. 8, p. e1020–e1030, ago. 2019.
50. SUBHERWAL, S. et al. Socioeconomic disparities in the use of cardioprotective
medications among patients with peripheral artery disease. Journal of the American
College of Cardiology, v. 62, n. 1, p. 51–57, jul. 2013.
51. SWAIN, J. et al. Vascular calcification in diabetic foot and its association with
calcium homeostasis. Indian Journal of Endocrinology and Metabolism, v. 16, n. 8, p.
450, 2012.
52. UNKART, J. T. et al. Burden of peripheral artery disease on mortality and incident
cardiovascular events. American Journal of Epidemiology, v. 189, n. 9, p. 951–962, 1
set. 2020.
53. UYAGU, O. D. et al. Quality assessment and comparative analysis on the
recommendations of current guidelines on screening and diagnosis of peripheral arterial
disease: A systematic review. BMJ Open, v. 12, n. 9, p. e061599, set. 2022.
54. VART, P. et al. Socioeconomic status and incidence of hospitalization with lower‐
extremity peripheral artery disease: Atherosclerosis risk in communities study. Journal
of the American Heart Association, v. 6, n. 8, p. e004995, 2 ago. 2017.
55. WRITING COMMITTEE MEMBERS et al. 2012
ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for
110
peripheral atherosclerotic vascular disease: A report of the American College of
Cardiology Foundation/American Heart Association Task Force on Clinical Data
Standards (Writing Committee to Develop Clinical Data Standards for Peripheral
Atherosclerotic Vascular Disease). Circulation, v. 125, n. 2, p. 395–467, 17 jan. 2012.
56. XU, C. et al. Predictive value of the ankle-brachial index for all-cause and cardiocerebrovascular mortality. Angiology, v. 74, n. 7, p. 649–656, ago. 2023. | pt_BR |